$19.12 billion
Tue July 16th, 2019
116th Congress
Sponsor: Sen. Lamar Alexander — R — TN
The bill would: (1) protect patients from surprise medical billing and reduce payments to some health care providers working in facilities where surprise bills are likely, (2) allow some generic or biosimilar drugs to enter the market earlier, on average, than under current law, (3) impose new rules for insurers’ contracts with pharmacy benefit managers and health care providers, (4) extend funding for community health centers and certain other federal health care programs, (5) increase access to health, cost, and quality information among patients, providers, and insurers, which would create new administrative responsibilities that increase costs for insurers and pharmacy benefit managers, and (6) impose intergovernmental and private-sector mandates by prohibiting certain medical billing practices, limiting other commercial activities, and prohibiting the sale of tobacco products to anyone under the age of 21, among many other duties.
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×